Erhalte eine Antwort von diesem Arbeitgeber
Dein Lebenslauf und dein Anschreiben, genau auf das zugeschnitten, was gesucht wird.
Proclinical partners with a clinical-stage biotechnology company to appoint a Director of Medicinal Chemistry in the San Francisco Bay Area. The role leads multidisciplinary drug discovery from hit identification through candidate nomination, overseeing DMPK, ADME/PK, pharmacology and toxicology considerations.
The successful candidate will guide strategy across internal and external teams, mentor scientists, and drive SAR-driven optimization, with a strong emphasis on peptide therapeutics,
Director, Medicinal Chemistry - Permanent - San Francisco Bay Area
Looking for an opportunity to lead high-impact drug discovery programmes and influence R&D strategy within an innovative clinical-stage biotechnology company?
Proclinical is working alongside an innovative, clinical-stage biotechnology company who are looking to appoint an experienced Director of Medicinal Chemistry to play a key leadership role within its discovery organisation.
This is an opportunity for an accomplished medicinal chemist to lead multidisciplinary drug discovery programmes from hit identification and lead optimisation through to development candidate selection, while managing and mentoring scientists and providing strategic scientific direction across internal and external research teams.
The successful candidate will combine deep expertise in medicinal chemistry and small molecule drug discovery with a strong understanding of DMPK, ADME, pharmacology and toxicology. Experience working with peptides, macrocycles or other complex modalities would be particularly valuable.
This is a senior scientific leadership position offering the opportunity to influence drug discovery strategy while remaining close to the science.
You will work across innovative discovery programmes, lead talented scientists and collaborate with specialists across medicinal chemistry, DMPK, pharmacology and computational drug design to help translate promising molecules into potential new medicines.